Pharma Journalist 8769 posts 0 comments

AstraZeneca announced that its Bydureon phase IIIb/IV EXSCEL (EXenatide Study of Cardiovascular Event Lowering) trial top-line results and met its primary safety objective of…
Read More...

GB Sciences announced that its subsidiary, Growblox Life Sciences has filed a patent application for the treatment of chronic pain and heart therapies based on myrcene-containing…
Read More...

DNAnexus announced that AstraZeneca  has selected its secure cloud-based platform for CGR (Centre for Genomics Research). Financial terms of the collaboration were not disclosed. The…
Read More...

Atox Bio announced that Reltecimod (previously AB103) successfully completed pre-specified futility analysis in patients with Necrotizing Soft Tissue Infections and will continue…
Read More...

Tom Privette has joined Acurian as vice president and head of global business development. He will be responsible to lead the commercial efforts of company sales organization worldwide.…
Read More...

Debiopharm International SA and ImmunoGen announced that Debiopharm has acquired ImmunoGen's IMGN529/Debio 1562, a clinical-stage anti-CD37 ADC (antibody-drug conjugates) for the…
Read More...

Palladio Biosciences announced that it has acquired global rights to lixivaptan from Chiesi USA to  develop it for Polycystic Kidney Disease (PKD), an orphan kidney disease for which…
Read More...

CROS NT announced an extension of its partnership with Medidata to provide customers with Medidata’s next-gen EDC and RTSM systems. Under the partnership, CROS NT will offer its…
Read More...

Worldwide Clinical Trials has appointed Karen Nowatkoski as Vice President of Clinical Operations and Site Management. She will oversee and provide global management for the team of…
Read More...

Tekni-Plex announced that it has acquired the assets of BrunaSeals which will become part of Tri-Seal, Tekni-Plex’s global closure liners business unit. Tri-Seal senior VP and…
Read More...